FY2025 EPS Estimates for Henry Schein Decreased by Analyst

Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Leerink Partnrs lowered their FY2025 earnings per share (EPS) estimates for shares of Henry Schein in a report released on Tuesday, November 5th. Leerink Partnrs analyst M. Cherny now expects that the company will post earnings of $5.20 per share for the year, down from their prior forecast of $5.31. The consensus estimate for Henry Schein’s current full-year earnings is $4.76 per share. Leerink Partnrs also issued estimates for Henry Schein’s FY2026 earnings at $5.67 EPS and FY2027 earnings at $6.22 EPS.

Several other research analysts also recently commented on HSIC. Evercore ISI raised their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday. Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 22nd. UBS Group reduced their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Finally, Robert W. Baird decreased their price target on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $77.50.

Henry Schein Trading Down 2.1 %

Shares of Henry Schein stock opened at $68.00 on Friday. Henry Schein has a 52-week low of $62.12 and a 52-week high of $82.63. The stock’s 50-day simple moving average is $70.51 and its 200 day simple moving average is $69.73. The stock has a market capitalization of $8.48 billion, a P/E ratio of 27.98, a P/E/G ratio of 2.00 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.42.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the previous year, the business posted $1.32 EPS. The firm’s quarterly revenue was up .4% compared to the same quarter last year.

Insider Activity at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.14% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in Henry Schein by 1.7% in the first quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock valued at $1,165,425,000 after acquiring an additional 260,537 shares during the last quarter. American Century Companies Inc. boosted its position in Henry Schein by 3.1% during the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock valued at $351,543,000 after buying an additional 162,477 shares during the period. Swedbank AB purchased a new stake in Henry Schein during the first quarter valued at about $215,998,000. Nuance Investments LLC boosted its position in Henry Schein by 22.3% during the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after buying an additional 414,748 shares during the period. Finally, Burgundy Asset Management Ltd. boosted its position in Henry Schein by 1.0% during the second quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock valued at $105,148,000 after buying an additional 16,476 shares during the period. Institutional investors own 96.62% of the company’s stock.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.